Home / Market News / $MMSI
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Needham Maintains Buy Rating and Raises Price Target for Merit Medical Systems

Oct 30, 2026, 11:37 AM UTC · Primary ticker $MMSI

Needham & Company reiterated its 'Buy' rating for Merit Medical Systems and increased its price target from $101 to $106. This adjustment suggests a potential upside of 13.5% from the stock's closing price, indicating continued analyst confidence in the company's future performance.

Needham & Company maintained its 'Buy' rating on Merit Medical Systems and raised its price target to $106 from $101. This analyst action signals continued positive sentiment and a belief in the company's growth prospects. For traders, this provides a short-term positive signal, potentially leading to increased buying interest as the new price target implies a significant upside. The long-term implication is that the market may re-evaluate MMSI's valuation based on this updated analyst outlook. The key opportunity for traders is to capitalize on potential upward momentum, though the risk remains that the stock may not reach the target or could be subject to broader market volatility.

$MMSI positive Analyst price target increase and maintained Buy rating
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.